NUDT21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.666000E-01
Normal-vs-Stage2
6.378200E-01
Normal-vs-Stage3
8.849700E-02
Normal-vs-Stage4
3.107000E-01
Stage1-vs-Stage2
7.243800E-01
Stage1-vs-Stage3
9.454100E-02
Stage1-vs-Stage4
4.523800E-02
Stage2-vs-Stage3
9.223700E-02
Stage2-vs-Stage4
1.461600E-02
Stage3-vs-Stage4
1.703890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.916600E-01
Normal-vs-AfricanAmerican
7.879200E-01
Normal-vs-Asian
1.491760E-01
Caucasian-vs-AfricanAmerican
1.905370E-01
Caucasian-vs-Asian
6.902000E-02
AfricanAmerican-vs-Asian
4.558400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.072600E-01
Normal-vs-Female
6.067200E-01
Male-vs-Female
8.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.872200E-01
Normal-vs-Age(41-60Yrs)
9.693600E-01
Normal-vs-Age(61-80Yrs)
4.556000E-01
Normal-vs-Age(81-100Yrs)
5.158600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.714400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.210200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.251800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.402360E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.174000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.779000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.370400E-01
Normal-vs-Daily Drinker
4.920200E-01
Normal-vs-Weekly Drinker
1.863760E-01
Normal-vs-Occasional Drinker
8.923000E-01
Normal-vs-Social Drinker
8.114800E-01
Non Drinker-vs-Daily Drinker
9.346800E-01
Non Drinker-vs-Weekly Drinker
3.174200E-01
Non Drinker-vs-Occasional Drinker
3.424000E-02
Non Drinker-vs-Social Drinker
2.509400E-01
Daily Drinker-vs-Weekly Drinker
5.078200E-01
Daily Drinker-vs-Occasional Drinker
9.871700E-02
Daily Drinker-vs-Social Drinker
3.608800E-01
Weekly Drinker-vs-Occasional Drinker
1.433920E-02
Weekly Drinker-vs-Social Drinker
9.881500E-02
Occasional Drinker-vs-Social Drinker
4.956800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.179200E-01
Normal-vs-Grade 2
4.459900E-02
Normal-vs-Grade 3
2.962000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.807550E-02
Grade 1-vs-Grade 3
2.018700E-03
Grade 1-vs-Grade 4
2.179200E-01
Grade 2-vs-Grade 3
1.358630E-01
Grade 2-vs-Grade 4
4.459900E-02
Grade 3-vs-Grade 4
2.962000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.342000E-01
Normal-vs-NonDiabetic
5.272000E-01
Diabetic-vs-NonDiabetic
3.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.752600E-01
Normal-vs-NoPancreatitis
5.134800E-01
Pancreatitis-vs-NoPancreatitis
7.448000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.521200E-01
Normal-vs-N1
6.271400E-01
N0-vs-N1
9.840800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.214000E-01
Normal-vs-TP53-NonMutant
5.288400E-01
TP53-Mutant-vs-TP53-NonMutant
1.044180E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
